Charles Schwab Investment Management Inc. Sells 11,046 Shares of Integer Holdings Corporation $ITGR

Key Points

• Charles Schwab Investment Management Inc. reduced its stake in Integer Holdings Corporation by 2.7%, selling 11,046 shares, and now owns 1.14% of the company valued at approximately $46.9 million.
• The stock's recent performance shows a 52-week range between $104.93 and $146.36, with an average price target from analysts currently at $140.25.
• Integer reported earnings of $1.55 per share for the last quarter, missing analysts' estimates, but experienced an 11.4% year-over-year revenue growth to $476 million.

Charles Schwab Investment Management Inc. lowered its position in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 2.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 397,542 shares of the medical equipment provider's stock after selling 11,046 shares during the period. Charles Schwab Investment Management Inc. owned 1.14% of Integer worth $46,914,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the company. TD Private Client Wealth LLC grew its stake in Integer by 5.8% during the first quarter. TD Private Client Wealth LLC now owns 1,524 shares of the medical equipment provider's stock valued at $180,000 after acquiring an additional 83 shares in the last quarter. Xponance Inc. grew its stake in Integer by 5.1% during the first quarter. Xponance Inc. now owns 2,518 shares of the medical equipment provider's stock valued at $297,000 after acquiring an additional 122 shares in the last quarter. Bessemer Group Inc. grew its stake in Integer by 73.1% during the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock valued at $35,000 after acquiring an additional 125 shares in the last quarter. Emerald Mutual Fund Advisers Trust grew its stake in Integer by 0.8% during the fourth quarter. Emerald Mutual Fund Advisers Trust now owns 19,867 shares of the medical equipment provider's stock valued at $2,633,000 after acquiring an additional 152 shares in the last quarter. Finally, Summit Investment Advisors Inc. grew its stake in Integer by 5.3% during the fourth quarter. Summit Investment Advisors Inc. now owns 3,488 shares of the medical equipment provider's stock valued at $462,000 after acquiring an additional 175 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Insider Buying and Selling

In related news, Director Martin C. Maxwell sold 8,720 shares of the company's stock in a transaction on Thursday, June 5th. The shares were sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the sale, the director directly owned 22,170 shares in the company, valued at $2,672,815.20. This represents a 28.23% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Donald J. Spence sold 14,739 shares of the company's stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the sale, the director owned 18,781 shares of the company's stock, valued at $2,260,856.78. This represents a 43.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.16% of the company's stock.

Integer Trading Down 0.5%

Shares of ITGR traded down $0.5820 during mid-day trading on Thursday, reaching $106.7180. The company's stock had a trading volume of 281,367 shares, compared to its average volume of 421,472. The stock has a market cap of $3.74 billion, a PE ratio of 47.01, a P/E/G ratio of 0.85 and a beta of 1.02. The company has a current ratio of 3.41, a quick ratio of 2.18 and a debt-to-equity ratio of 0.72. Integer Holdings Corporation has a 52 week low of $104.93 and a 52 week high of $146.36. The company's fifty day moving average price is $113.91 and its two-hundred day moving average price is $119.40.

Integer (NYSE:ITGR - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing analysts' consensus estimates of $1.57 by ($0.02). The business had revenue of $476.00 million during the quarter, compared to the consensus estimate of $464.37 million. Integer had a return on equity of 12.27% and a net margin of 4.61%.The company's revenue was up 11.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.30 earnings per share. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. On average, analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently commented on ITGR. Citigroup raised shares of Integer from a "hold" rating to a "strong-buy" rating and boosted their price objective for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Raymond James Financial dropped their target price on shares of Integer from $150.00 to $143.00 and set an "outperform" rating for the company in a research report on Friday, July 25th. Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. Truist Financial dropped their target price on shares of Integer from $145.00 to $137.00 and set a "buy" rating for the company in a research report on Friday, July 25th. Finally, Benchmark dropped their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research report on Friday, April 25th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Integer currently has an average rating of "Buy" and an average price target of $140.25.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.